Thu, June 22, 2023

Sean Dodge Maintained (CDMO) at Buy with Decreased Target to $17 on, Jun 22nd, 2023

Sean Dodge of RBC Capital, Maintained "Avid Bioservices, Inc." (CDMO) at Buy with Decreased Target from $20 to $17 on, Jun 22nd, 2023.

Sean has made no other calls on CDMO in the last 4 months.



There is 1 other peer that has a rating on CDMO. Out of the 1 peers that are also analyzing CDMO, 0 agree with Sean's Rating of Hold.



This is the rating of the analyst that currently disagrees with Sean


  • Paul Knight of "Keybanc" Upgraded from Hold to Buy and Held Target at $20 on, Tuesday, March 14th, 2023